Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial.

Black PC, Basen-Engquist K, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncoso P, Pettaway CA.

BJU Int. 2007 Jul;100(1):63-9.

PMID:
17552954
[PubMed - indexed for MEDLINE]
2.

Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.

Di Lorenzo G, Perdonà S, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Autorino R.

J Urol. 2005 Dec;174(6):2197-203.

PMID:
16280763
[PubMed - indexed for MEDLINE]
3.

Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.

Yoon FH, Gardner SL, Danjoux C, Morton G, Cheung P, Choo R.

J Urol. 2008 Oct;180(4):1438-43; discussion 1443-4. doi: 10.1016/j.juro.2008.06.029. Epub 2008 Aug 16.

PMID:
18710743
[PubMed - indexed for MEDLINE]
4.

Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.

Namiki S, Satoh T, Baba S, Ishiyama H, Hayakawa K, Saito S, Arai Y.

Urology. 2006 Dec;68(6):1230-6. Epub 2006 Dec 4.

PMID:
17141839
[PubMed - indexed for MEDLINE]
5.

Prospective longitudinal comparative study of health-related quality of life in patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.

Kobuke M, Saika T, Nakanishi Y, Ebara S, Manabe D, Uesugi T, Nose H, Arata R, Tsushima T, Nasu Y, Kumon H.

Acta Med Okayama. 2009 Jun;63(3):129-35.

PMID:
19571899
[PubMed - indexed for MEDLINE]
Free Article
7.

Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.

Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW.

J Endourol. 2007 Dec;21(12):1521-31. doi: 10.1089/end.2007.9875.

PMID:
18186694
[PubMed - indexed for MEDLINE]
8.

How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?

Choo R, Chander S, Danjoux C, Morton G, Pearce A, Deboer G, Szumacher E, Loblaw A, Cheung P, Woo T.

Can J Urol. 2005 Feb;12(1):2547-52.

PMID:
15777493
[PubMed - indexed for MEDLINE]
9.

Effect of adjuvant androgen deprivation on thyroid function tests in prostate cancer patients.

Salminen E, Koskinen A, Backman H, Nurmi M.

Anticancer Drugs. 2004 Apr;15(4):351-6.

PMID:
15057139
[PubMed - indexed for MEDLINE]
10.

Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.

Kang SH, Kim JW, Bae JH, Park HS, Moon DG, Yoon DK, Cheon J, Kim JJ.

Asian J Androl. 2006 Sep;8(5):629-36.

PMID:
16847531
[PubMed - indexed for MEDLINE]
Free Article
11.

A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.

Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M.

Jpn J Clin Oncol. 2008 Jul;38(7):480-5. doi: 10.1093/jjco/hyn059. Epub 2008 Jul 11.

PMID:
18621847
[PubMed - indexed for MEDLINE]
Free Article
12.

Determining dosing intervals for luteinizing hormone releasing hormone agonists based on serum testosterone levels: a prospective study.

Pathak AS, Pacificar JS, Shapiro CE, Williams SG.

J Urol. 2007 Jun;177(6):2132-5; discussion 2135.

PMID:
17509298
[PubMed - indexed for MEDLINE]
13.

Kinetics of testosterone recovery in clinically localized prostate cancer patients treated with radical prostatectomy and subsequent short-term adjuvant androgen deprivation therapy.

Dai B, Qu YY, Kong YY, Ye DW, Yao XD, Zhang SL, Zhang HL, Yang WY.

Asian J Androl. 2013 Jul;15(4):466-70. doi: 10.1038/aja.2012.169. Epub 2013 May 27.

PMID:
23708460
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.

Choo R, Pearce A, Danjoux C, Morton G, Deboer G, Szumacher E, Loblaw A, Cheung P.

Eur Urol. 2007 Dec;52(6):1645-50. Epub 2006 Nov 15.

PMID:
17140722
[PubMed - indexed for MEDLINE]
15.

Dissociation of sexual function and sexual bother following autologous sural nerve grafting during radical prostatectomy.

Kuwata Y, Muneuchi G, Igawa HH, Tsukuda F, Inui M, Kakehi Y.

Int J Urol. 2007 Jun;14(6):510-4.

PMID:
17593095
[PubMed - indexed for MEDLINE]
16.

Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.

Morote J, Orsola A, Planas J, Trilla E, Raventós CX, Cecchini L, Catalán R.

J Urol. 2007 Oct;178(4 Pt 1):1290-5. Epub 2007 Aug 14.

PMID:
17698136
[PubMed - indexed for MEDLINE]
17.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
[PubMed - indexed for MEDLINE]
18.

The change in the dihydrotestosterone level in the prostate before and after androgen deprivation therapy in connection with prostate cancer aggressiveness using the Gleason score.

Nishiyama T, Ikarashi T, Hashimoto Y, Wako K, Takahashi K.

J Urol. 2007 Oct;178(4 Pt 1):1282-8; discussion 1288-9. Epub 2007 Aug 14.

PMID:
17698092
[PubMed - indexed for MEDLINE]
19.

Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.

Johansson E, Bill-Axelson A, Holmberg L, Onelöv E, Johansson JE, Steineck G; Scandinavian Prostate Cancer Group Study No 4.

Eur Urol. 2009 Feb;55(2):422-30. doi: 10.1016/j.eururo.2008.08.054. Epub 2008 Sep 2.

PMID:
18783877
[PubMed - indexed for MEDLINE]
20.

Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.

Arcangeli G, Strigari L, Arcangeli S, Petrongari MG, Saracino B, Gomellini S, Papalia R, Simone G, De Carli P, Gallucci M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):975-82. doi: 10.1016/j.ijrobp.2008.12.045. Epub 2009 Apr 22.

PMID:
19395188
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk